MDIC Releases Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices: Register for 10/2/20 Webinar

September 11, 2020

The Medical Device Innovation Consortium (MDIC) has announced the release of Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

MDIC states the report focuses on providing evidence-based best practices for enhancing communication with patients about medical devices so that patients can make informed treatment decisions.

“Patients considering a medical device need to understand the implications of available treatment options. This report helps decision-makers better understand how to communicate in ways that will resonate with patients,” said Scott Goates, Ph.D., Senior Advisor of Health Economics and Outcomes Research at Abbott and Chair of the Science of Patient Input Communication Working Group. The working group wrote the report on behalf of MDIC’s Science of Patient Input Steering Committee.

The MDIC report identifies characteristics of providers and patients, and the way in which the scientific and medical information is disseminated, that can affect patients’ comprehension and decision-making.

“The patient perspective that is included in this report will help physicians and medical device manufacturers understand what patients really need,” says heart patient and patient advocate Heidi Dohse. “This report provides patient insights in a way that is actionable for physicians and medical device manufacturers.”

Dohse has been living with pacemakers for 37 years since she was diagnosed with irregular junctional tachycardia at age 19. Back then, no one told her that there were different types of pacemakers and her first pacemaker wasn’t responsive to her needs as an athlete. Within six months, Dohse had a second procedure to replace her first pacemaker with another pacemaker that was better suited to her needs and goals. Dohse shares her story in the report.

“Patient engagement during the treatment decision-making process is key. This requires that all medical device stakeholders understand how to appropriately communicate with patients about medical devices,” said Pamela Goldberg, MBA, President, and CEO of MDIC. “The report is a practical resource that summarizes key terms and provides evidence-based tools, and resources to help develop an effective communication strategy.”

The report is also part of a larger movement to “make sure the patient’s voice is front and center in making decisions about medical devices,” said Goates. That movement includes MDIC’s Science of Patient Input program, which focuses on integrating the patient’s perspective and preferences in the design, clinical development, and regulatory review of innovative medical technologies.

“It’s really important that MDIC is including the patient voice and listening to the patient perspective,” said Dohse.

Read Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices.

Register for the webinar on communicating benefit, risk, and uncertainty for medical devices on Friday, October 2, 2020, at 2 pm ET.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.